The Sotrovimab arm of the "PROphylaxis for paTiEnts at risk of COVID-19 infecTion (Protect-V)” trial

Project Details

Short titleThe Sotrovimab arm of the "PROphylaxis for paTiEnts at risk of COVID-19 infecTion (Protect-V)” trial
StatusActive
Effective start/end date1/02/2231/01/24

Funding

  • Glaxosmithkline
  • Glaxosmithkline
  • Glaxosmithkline